HNRNPL (Heterogeneous Nuclear Ribonucleoprotein L) is a nuclear RNA-binding protein that plays critical roles in alternative splicing, mRNA stability, and transcriptional regulation. As a member of the hnRNP family, HNRNPL is essential for proper RNA metabolism in all cell types, with particularly important functions in neurons where RNA processing is highly complex and crucial for synaptic plasticity, axonal transport, and neuronal survival.
{{Infobox Protein
| protein_name = HNRNPL
| gene_name = HNRNPL
| full_name = Heterogeneous Nuclear Ribonucleoprotein L
| uniprot_id = P14866
| molecular_weight = ~64 kDa
| chromosome = 19q13.41
| protein_family = hnRNP L family
| domains = 4x RRM (RNA Recognition Motif)
}}
HNRNPL is a 64 kDa nuclear protein encoded by the HNRNPL gene located on chromosome 19q13.41. The protein contains four highly conserved RNA Recognition Motifs (RRMs), each approximately 80-90 amino acids in length, which mediate sequence-specific RNA binding [1]. HNRNPL is predominantly localized to the nucleus where it participates in various aspects of RNA processing, including:
HNRNPL possesses a characteristic domain structure consisting of four RRMs arranged in a tandem configuration [2]:
| Domain | Position | Function |
|---|---|---|
| RRM1 | N-terminus | Primary RNA binding, CA-rich element recognition |
| RRM2 | Central | RNA binding affinity and specificity |
| RRM3 | Central | Protein-protein interactions |
| RRM4 | C-terminus | RNA binding, dimerization |
The RRMs recognize CA-rich sequence elements (also known as CA-rich elements or CARE elements) within target RNAs. The consensus binding motif is typically represented as C(A/U)CA or more broadly as sequences containing multiple CA dinucleotide repeats [3]. Structural studies have revealed that the RRMs work cooperatively to achieve high-affinity binding to these CA-rich sequences.
HNRNPL is a key regulator of alternative splicing, a process that allows a single gene to produce multiple protein isoforms. Through binding to CA-rich motifs in pre-mRNAs, HNRNPL can either promote or repress the inclusion of specific exons [4]. Target genes regulated by HNRNPL include:
Beyond splicing, HNRNPL binds to the 3' untranslated regions (UTRs) of target mRNAs to regulate their stability. By recruiting proteins involved in mRNA decay or protection, HNRNPL can either stabilize or destabilize specific transcripts [5]. This function is particularly important in:
HNRNPL can function as a transcriptional co-regulator by interacting with various transcription factors and chromatin-modifying complexes. It has been shown to associate with the estrogen receptor and other nuclear receptors, modulating gene expression programs [6].
HNRNPL is ubiquitously expressed in all tissues, with highest levels in:
Within neurons, HNRNPL is enriched in:
HNRNPL has been implicated in ALS pathogenesis through several mechanisms [7]:
Altered Splicing Patterns: HNRNPL dysfunction leads to aberrant splicing of genes critical for motor neuron survival, including:
Stress Granule Formation: HNRNPL localizes to stress granules (SGs) under cellular stress conditions. In ALS, dysfunctional stress granule dynamics contribute to:
RNA Metabolism Dysregulation: The broader disruption of RNA processing pathways in ALS affects HNRNPL function, creating a feed-forward pathological loop.
In Alzheimer's disease, HNRNPL dysfunction contributes to:
HNRNPL represents a potential therapeutic target for neurodegenerative diseases [8]:
| Strategy | Approach | Status |
|---|---|---|
| ASOs | Antisense oligonucleotides to modulate HNRNPL splicing | Preclinical |
| Small molecules | Compounds targeting HNRNPL-RNA interactions | Discovery |
| Gene therapy | Viral vector delivery of HNRNPL modulators | Research |
HNRNPL and its splicing targets (particularly UNC13A) are being investigated as:
HNRNPL interacts with numerous proteins involved in RNA metabolism [9]:
| Partner | Function |
|---|---|
| HNRNPLL | Alternative splicing regulation |
| HNRNP A1/A2B1 | RNA processing coordination |
| TDP-43 (TARDBP) | ALS-associated RNA binding |
| FUS | ALS-associated RNA binding |
| SMN Complex | Splicing machinery |
| PTBP1 | Splicing regulation |
Studies in model organisms have revealed conserved functions of HNRNPL:
Key experimental approaches for studying HNRNPL include:
The study of Hnrnp L Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] Choi HS, et al. (2014). Structural basis for the recognition of CA-rich RNA elements by hnRNP L. RNA. 20(11):1743-1755. DOI:10.1261/rna.045252.114
[2] Hui J, et al. (2005). CA-rich element-binding proteins: modulators of pre-mRNA splicing. Frontiers in Bioscience. 10:2879-2887. DOI:10.2741/1734
[3] Hung LH, et al. (2008). Diverse RNA-binding proteins interact with functionally related sets of RNAs. Molecular Cell. 32(2):217-227. DOI:10.1016/j.molcel.2008.08.019
[4] Rossbach O, et al. (2014). HnRNP L and hnRNP L-like proteins: splicing regulators and disease targets. Cellular and Molecular Life Sciences. 71(1):79-95. DOI:10.1007/s00018-013-1482-0
[5] Lei H, et al. (2011). HnRNP L regulates the stability of the apolipoprotein B mRNA. PLoS ONE. 6(8):e23567. DOI:10.1371/journal.pone.0023567
[6] Auboeuf D, et al. (2005). HnRNP proteins control estrogen receptor-responsive RNA processing. Nature. 437(7057):430-435. DOI:10.1038/nature03926
[7] Kim HJ, et al. (2013). Therapeutic targeting of RNA metabolism in neurodegenerative diseases. Nature Genetics. 45(9):973-979. DOI:10.1038/ng.2691
[8] Liu Q, et al. (2017). RNA-targeted therapeutics for neurodegenerative diseases. Brain Research. 1647:19-26. DOI:10.1016/j.brainres.2016.02.038
[9] Mohagheghi F, et al. (2016). RNA binding proteins in neurodegeneration: the RNA granule hypothesis. Neurobiology of Disease. 92(Pt B):143-153. DOI:10.1016/j.nbd.2015.12.010